• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
1AI
Click for more information
0.00% 1.0¢

ALGORAE PHARMACEUTICALS LIMITED

Market Cap $16.86M  ! watchlist Created with Sketch. Add to my watchlist
Healthcare Biotechnology

Algorae Pharmaceuticals Limited, formerly Living Cell Technologies Limited, is an... Algorae Pharmaceuticals Limited, formerly Living Cell Technologies Limited, is an Australia-based pharmaceutical development company. The Company is focused on discovering and developing novel treatments for medical conditions with under met medical needs. Its programs include AlgoraeOS, Dementia and Parkinson’s. Its drug candidates include NTCELL for Parkinson’s disease and the AI-116 combination drug candidate for dementia. AlgoraeOS is a closed-loop platform, leveraging advanced computational tools to generate novel insights in-silico that are being developed to initiate or accelerate therapeutic programs. The AI-116 is a novel combination drug candidate made up of cannabidiol (CBD) and an off-patent pharmaceutical ingredient. The NTCELL is an alginate coated capsule product containing clusters of neonatal porcine choroid plexus cells that are injected into the damaged site within the brain to target the treatment of Parkinson’s disease.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
1AI
Ann: Application for quotation of securities - 1AI 		26/04/24 0 176
26/04/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  176 
1AI
Ann: Positive results from AI-116 in vitro studies 		25/04/24 17 5.7K
25/04/24 Last post  Moreforme Comments Created with Sketch.  17  Views Created with Sketch.  5.7K 
1AI
Ann: Proposed issue of securities - 1AI 		23/04/24 0 180
23/04/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  180 
1AI
Ann: Application for quotation of securities - 1AI 		22/04/24 0 190
22/04/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  190 
1AI
Ann: Notification of cessation of securities - 1AI 		22/04/24 0 194
22/04/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  194 
1AI
Ann: 1AI Corporate Presentation 		18/04/24 2 715
18/04/24 Last post  Magilla208 Comments Created with Sketch.  2  Views Created with Sketch.  715 
1AI
Ann: Artificial Intelligence Platform Update 		04/04/24 26 8.8K
04/04/24 Last post  Heliport Comments Created with Sketch.  26  Views Created with Sketch.  8.8K 
1AI
Ann: Results of Meeting 		26/03/24 0 264
26/03/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  264 

See All Discussions arrow Created with Sketch.

Timeline

Application for quotation of securities - 1AI
26 Apr 16:33
 
Proposed issue of securities - 1AI
23 Apr 16:38
 
Application for quotation of securities - 1AI
22 Apr 16:21
 
Notification of cessation of securities - 1AI
22 Apr 16:19
 
1AI Corporate Presentation
18 Apr 09:07
 
Positive results from AI-116 in vitro studies
08 Apr 09:28
 
View More arrow Created with Sketch.

Featured News

BHP BHP confirms £31.1B takeover bid for Anglo American
right-arrow Created with Sketch.
NCK Nick Scali moves into the UK market through Fabb Furniture acquisition
right-arrow Created with Sketch.
RCE Recce wins safety board approval to dose 4g in R327 UTI infusion trial
right-arrow Created with Sketch.
ASM Aust Strategic sees Canada join US in possible funding push for Dubbo
right-arrow Created with Sketch.
NEWS Recharged Prospects: ‘Watts’ on the horizon for copper & lithium
right-arrow Created with Sketch.
RDN Raiden's key target areas found drill ready in cultural heritage survey
right-arrow Created with Sketch.
(20min delay)
Last
1.0¢ 		Change
0.000(0.00%) 		Mkt cap ! $16.86M
Open High Low Value Volume
1.1¢ 1.1¢ 1.0¢ $18.53K 1.835M

Buyers (Bids)

No. Vol. Price($)
4 2544890 1.0¢
 

Sellers (Offers)

Price($) Vol. No.
1.1¢ 1298025 3
View Market Depth
Last trade - 16.10pm 26/04/2024 (20 minute delay) ?
Last
1.0¢ 		  Change
0.000 ( 0.00 %)
Open High Low Volume
1.1¢ 1.1¢ 1.0¢ 880000
Last updated 14.21pm 26/04/2024 ?
1AI (ASX) Chart

Top Stories

Crypto world awaits overnight Bitcoin halving event

The four-yearly Bitcoin halving is set to happen in the early hours of tomorrow morning (Saturday, April 20) - it's an event that industry leader Swyftx likened to 'the Olympic Games for the crypto industry'.
Raiden’s jump into lithium territory in WA’s Pilbara echoes earlier journey by Azure In its bid to define a noteworthy lithium deposit in WA’s Pilbara region, Raiden Resources is following in the footsteps of another explorer.
Recce Pharmaceuticals up 6% on new antibiotic production milestone Recce Pharmaceuticals (ASX:RCE) is trading up more than 6 per cent after producing a 5000-dose batch of its new antibiotic RECCE 327 (R327) under Good Manufacturing Practises (GMP) standards.
Are there gains to be made with the grocery giants? There is a growing storm of controversy around Coles (ASX:COL) and Woolworths (ASX:WOW) as they face intense scrutiny over price hikes and supplier pressures in a Senate inquiry. This raises an interesting question as to whether investors should cut ties with these corporate giants or wheth...
BHP confirms £31.1B takeover bid for Anglo American BHP HAS confirmed its offer to takeover fellow mining giant Anglo American plc, following press speculation of a potential deal.which had unsettled shareholder groups and financial firms in London, and provoked criticism from a South African government minister.

Featured News

CC9 Chariot ends quarter charged up on lithium find in Wyoming
right-arrow Created with Sketch.
BHP BHP confirms £31.1B takeover bid for Anglo American
right-arrow Created with Sketch.
NCK Nick Scali moves into the UK market through Fabb Furniture acquisition
right-arrow Created with Sketch.
RCE Recce wins safety board approval to dose 4g in R327 UTI infusion trial
right-arrow Created with Sketch.
ASM Aust Strategic sees Canada join US in possible funding push for Dubbo
right-arrow Created with Sketch.
NEWS Recharged Prospects: ‘Watts’ on the horizon for copper & lithium
right-arrow Created with Sketch.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.